Intralesional methotrexate for keratoacanthomas: A retrospective cohort study

被引:9
作者
Smith, Cory [1 ]
Srivastava, Divya [1 ]
Nijhawan, Rajiv I. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, 5939 Harry Hines Blvd,Ste 400, Dallas, TX 75390 USA
关键词
D O I
10.1016/j.jaad.2020.03.096
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:904 / 905
页数:2
相关论文
共 4 条
[1]   Keratoacanthoma (KA): An update and review [J].
Kwiek, Bartlomiej ;
Schwartz, Robert A. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (06) :1220-1233
[2]  
Lonsdorf AS, 2019, FITZPATRICKS DERMATO
[3]   Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate [J].
Moss, Max ;
Weber, Emma ;
Hoverson, Kara ;
Montemarano, Andrew D. .
DERMATOLOGIC SURGERY, 2019, 45 (07) :877-883
[4]   Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil [J].
Que, Syril Keena T. ;
Compton, Leigh A. ;
Schmults, Chrysalyne D. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) :111-122